PHARMAGEST INTERACTIVE : shares transferred to compartment B


Villers-lès-Nancy, 15 January 2013 - 18:00 (CET)
PRESS RELEASE

PHARMAGEST INTERACTIVE SHARES TRANSFERRED TO COMPARTMENT B

PHARMAGEST INTERACTIVE is proud to announce today that its shares will be transferred to Compartment B of the NYSE Euronext Paris(TM) with effect from 17 January.

For the record, Compartment B groups together quoted companies with market valuations of between 1 billion euros and 150 million euros. On 31 December 2012, the market valuation of PHARMAGEST INTERACTIVE was 182.08 million euros.

The changes of compartment were officially announced to market members by means of a notice to the market from NYSE Euronext on Monday 14 January 2013 and will take effect from 17 January 2013. This change has no impact on the fact that PHARMAGEST INTERACTIVE shares belong to the NYSE Euronext indices.

Thierry CHAPUSOT, Chairman of the Board of Directors of PHARMAGEST INTERACTIVE comments: "Following the announcement last December of our admission to the SRD (Deferred Settlement Service) label, today we are very proud to announce the transfer of our shares to compartment B. This operation will enable PHARMAGEST INTERACTIVE shares to benefit from greater visibility in not only the European financial community but also the international one."

About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in computer systems for pharmacies, with a 43.5 % share of the market, 9,800 clients and more than 700 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12 % market share in Belgium and Luxembourg through its subsidiary SABCO.

 

As a privileged partner to pharmacists for almost 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high potential E-Business E-Media activity intended for laboratories.

 

The PHARMAGEST Group is also developing previously unpublished software solutions for Retirement Homes, (Care Homes and day centres for the elderly), through its subsidiary MALTA INFORMATIQUE.

 

The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services® ), creator of value for the patient, pharmacist and laboratory, dynamizes sales, optimizes purchases and enriches advice to the patient. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients.

 

At the heart of the digital revolution that is gradually establishing itself in the daily life of health professionals and patients alike, at the beginning of 2012, the PHARMAGEST Group created an e-Health business, bringing together the subsidiaries DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (intelligent pill dispenser DO-Pill SecureTM).
 
 

Listed on the NYSE Euronext Paris(TM) - Compartment C until 16 January 18:00

Eligible for the Deferred Settlement Service (SRD) Long-only

Indices CAC ® SMALL90 and CAC ® All-Tradable by inclusion
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP

Find out the latest news from the PHARMAGEST group at www.pharmagest.com

CONTACTS

Analyst and Investor Relations:
Administrative and Financial Director: Jean-Yves SAMSON
Tel: 03 83 15 90 67 jean-yves.samson@pharmagest.com
Press Relations:
FIN'EXTENSO - Isabelle APRILE
Tel. 01 39 97 61 22 - i.aprile@finextenso.fr


Attachments

Pharmagest : shares transferred to compartment B